menu
The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%- Roots Anaysis
The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%- Roots Anaysis
Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”, covering key aspects of the industry and identifying future growth opportunities.

To order this 310+page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html

 

Key Market Insights

§  Many small / macro molecule-based STING pathway modulators are currentlybeing evaluated as monotherapies as well as in combination with other drugs

§ The pipeline features candidates targeting differenttherapeutic areas and designed for administration through a variety of routes;majority of such therapeutics are being developed as third-line and second-linetreatments

§ In recent years, several well funded start-ups have enteredthis field of research, and are gradually developing proprietary products basedon the STING pathway for the treatment of a variety of indications

§ In addition, a number of big pharmaceutical players havealso partnered with developers focused on STING targeting molecules in order toexpand their respective capabilities in this upcoming field of pharmacology

§ Published scientific literature indicates that bothindustry and academic players have made equal contributions to the innovationin this field; the major focus of such studies is presently on anti-cancertherapeutics

§ Several non-profit organizations have extended financialsupport to aid research efforts in this domain; the current focus appears to beon drug development and disease modelling studies

§ Foreseeing a lucrative future, private and public investorshave invested capital worth over USD 2.5 billion, across more than 80instances, in companies involved in STING pathway research

§ The rising interest is also reflected in recent partnershipactivity, involving the active participation of both international andindigenous companies; majority of the deals have been focused on noveltechnology platforms

§ Multiple companies are developing novel technologyplatforms for enhancing the research and development of STING pathway targetingtherapeutics

§ Technology developers are expected to continue relying onlicensing agreements involving different STING modulators as their primarysource of revenues in the foreseen future

 

For more information, please visit https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com